The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy [Corrigendum]
Yang M, Qin X, Qin G, Zheng X. Onco Targets Ther. 2019;12:2171–2180. On page 2172, Chemotherapy regimens section in Table 1, Platinum + platinum (TP) should have been Docetaxel + platinum (TP); Platinum + cyclophosphamide (TC) should have been...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-07-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | https://www.dovepress.com/corrigendum-diagnostic-and-prognostic-roles-of-irak1-in-breast-ca-peer-reviewed-article-OTT |